companydata.dkcompanydata.dk

LUNDBECK PHARMA A/S: Financial statements 2019

CVR: 56750215

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

LUNDBECK PHARMA A/S (CVR 56750215) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 17,287,000 and a net result of DKK 497,000 compared with DKK 736,000 the year before. That is a decrease of 5.8% compared with the year before. The profit margin was 2.9%. Equity in the 2019 report amounted to DKK 3,741,000. The solvency ratio was 26.8%. The company had 18 employees in the financial year.

Revenue
DKK 17,287,000
Gross Profit
DKK 1,272,000
Profit/Loss
DKK 497,000
Equity
DKK 3,741,000
Total Assets
DKK 13,965,000
Employees
18

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201917.3 mio.1.3 mio.497 t.3.7 mio.18
201818.4 mio.1.7 mio.736 t.3.8 mio.18
201719.7 mio.764 t.365 t.3.3 mio.14
201620.8 mio.2.3 mio.48 t.3 mio.8
201527 mio.4.9 mio.-129 t.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Thomas Bo Bjørn Klee joins the board of LUNDBECK PHARMA A/SJul 1, 2019

As of July 1, 2019, Thomas Bo Bjørn Klee has joined the board of directors of LUNDBECK PHARMA A/S.

Christoffer Dahl leaves the board of LUNDBECK PHARMA A/SJul 1, 2019

As of July 1, 2019, Christoffer Dahl has left the board of directors of LUNDBECK PHARMA A/S.

Thomas Bo Bjørn Klee joins LUNDBECK PHARMA A/S as adm. dir.Jul 1, 2019

As of July 1, 2019, Thomas Bo Bjørn Klee is registered as adm. dir. of LUNDBECK PHARMA A/S.

Christoffer Dahl steps down as director of LUNDBECK PHARMA A/SJul 1, 2019

As of July 1, 2019, Christoffer Dahl has stepped down as director of LUNDBECK PHARMA A/S.

LUNDBECK PHARMA A/S: The 2018 annual report is outMar 22, 2019

LUNDBECK PHARMA A/S has published its annual report for 2018. Revenue came to DKK 18,357,000, and the net result was DKK 736,000.

About LUNDBECK PHARMA A/S

LUNDBECK PHARMA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1958. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANS LUNDBECK A/S. The management consists of Søren Klein-Kristensen. The board consists of Michala Fischer-Hansen (chair), Søren Klein-Kristensen and Thomas Bo Bjørn Klee. The company is owned by H. LUNDBECK A/S. The company has 18 employees (2026). In 2025, the company reported revenue of DKK 18,887,000 and a net result of DKK 2,291,000 compared with DKK 1,820,000 the year before. Equity in the 2025 report amounted to DKK 3,378,000.

Source: annual report 2025, Danish Business Authority